Skip to main content

Posts

F STOCK WRITE UP

F(FORD) P/E: 10.9 GAAP DILUTED EPS Y-O-Y GROWTH LAST QUARTER: -$.67 SECTOR: CONSUMER DURABLES ASSETS-LIABILITIES: 1.21 DIVIDEND: 4.79% Ford is a well-known brand, largely due to its successful models such as its F-series trucks, and its position as the 2nd-best selling automobile maker in the US, according to Statista. The stock has fallen steadily since its high of $17.5 in 7/2014. While backed by some solid technical facts as a function of its proven products, the company lacks growth in recent years, which has led to its stock dropping in value. According to the website Statista, Ford is slightly behind GM in total revenue, and markedly behind Volkswagen, the leading automotive manufacturer. Ford reported its own global market share was down 1/10 th of a percentage point from the prior year. However, Ford does possess a consistently best-selling brand in its F-series truck, the best-selling in its category over the past 40 years. Additionally, Ford p...

USE THE NEWS SUMMARY

USE THE NEWS MARIA BARTIROMO SUMMARY The book opens stating that market volatility increased due to the 2001 recession.  While the type of news has changed, fundamentals of important driving factors of news have not.  Between the years of 1983 and 2000, the number of individual investors grew from 42 million to 85 million. Bartiromo became involved in the field by interviewing fund managers, investment banks, and CEOs to discern which indicators they valued.  She utilizes analyst reports frequently, which are typically provided as part of institutional bank packages, or online if a journalist cites the report for an article.  She focuses her efforts on sectors experiencing the highest level of growth. In order to analyze an industry, she creates a list of specific issues for that industry.  When investing in a particular stock within an industry, she develops questions affecting news headlines, and questions affecting fundamentals.  She a...

AMGN STOCK WRITE UP

AMGN P/E: 16.1 GAAP EPS Y-O-Y GROWTH LAST QUARTER: $.22 SECTOR: HEALTH TECHNOLOGY ASSETS-LIABILITIES: 1.62 DIVIDEND: 2.54% Amgen is a leading biotech company with a solid financial foundation. It has managed to reduce its spending on research and development while increasing revenue through its sales of established drugs such as Enbrel, and Prolia. The company has several rapidly growing drugs that are newer to the market, with many drugs in the company's pipeline. In its last quarter, Amgen posted 7.7% revenue growth with 7.5% net income growth. The company spent less, however, in the most recent quarter when compared with the comparable quarter from the prior year, on research and development. The reduction in operating margin came from an increased interest expense in the quarter. Although the company spent less on research and development, its revenue did increase. Amgen is continuing to innovate despite reduced research and development b...

GOOG STOCK WRITE UP

GOOG (ALPHABET INC) P/E: 31.7 GAAP DILUTED EPS GROWTH Q4 '15 to Q4 '16: $.50 SECTOR: TECHNOLOGY SERVICES ASSETS-LIABILITIES: 5.8 DIVIDEND: NONE This stock is a new addition to my portfolio. The price-to-earnings multiple is higher than my target price-to-earnings multiple, but I decided to purchase the stock due to its solid year-over-year EPS growth, positive chart alignment, positive cash flow, ubiquitous market presence, and rapid growth in the technology sector. I believe this stock will head much higher, and that its earnings will keep up with the rapid pace of its growth to ensure its stability. Google became a popular product due to its excellent search engine. As a result of its success, with approximately 80.5% of global market share according to a recent survey, Google has built a strong revenue base through its advertising services. However, Google has taken the challenge of expanding its services beyond the search engine field i...

CLS STOCK WRITE UP

CLS (CELESTICA) P/E: 15.1 GAAP DILUTED EPS Y-O-Y GROWTH LAST QUARTER: $.14 SECTOR: ELECTRONIC TECHNOLOGY ASSETS-LIABILITIES: 1.78 DIVIDEND: none Celestica, a spinoff from IBM, manufactures electronics and provides supply chain services for a variety of businesses. The company has successfully improved upon its operating margins and revenue during its last fiscal year. Reporting April 20 th before market open, the company will try to beat Wall street expectations of $.28 and its own guidance of $.24-$.3. Celestica provides services for the communications, consumer, server, and storage industries, as well as working in diversified companies. This wide array of services gives Celestica the opportunity to expand on revenue when one of its segments is lagging. Rather than developing new products to boost revenue, Celestica must rely on increasing customer satisfaction by managing supply chains well for its clients. In order to showcase their services,...

MHK STOCK WRITE UP

MHK (MOHAWK INDUSTRIES) P/E: 18.6 GAAP DILUTED EPS Y-O-Y GROWTH LAST QUARTER: $.44 SECTOR: CONSUMER DURABLES ASSETS-LIABILITIES: 2.312 DIVIDEND: none Mohawk industries is a stock you probably have not heard of, unless you are a DIY enthusiast or work in homebuilding. Mohawk is a supplier of carpet, wall tiles, and laminate. They have posted consistent revenue increases over the last 5 years. In 2016, the company spent a record amount on capital investing in order to continue the growth of its business, and plans to expand on that strategy in 2017. The company is dedicating itself to expansion of manufacturing capacity and development of new products, rather than acquisitions. This capital expenditure has not slowed the company's growth, however, as its operating income margin has also increased over the last 5 years. Jeffrey Lorberbaum, the company's CEO, is the son of the owners of a flooring company which was acquired by Mohawk. Lorberbaum...

UNH STOCK WRITE UP

UNH (UNITED HEALTHCARE) P/E: 23.2 GAAP DILUTED EPS GROWTH Q4 '15 TO Q4 '16: $.71 SECTOR: HEALTH SERVICES ASSETS-LIABILITIES: 2.54 DIVIDEND: 1.52% In 2015, UNH was the largest provider of health insurance in the United States of America. Unless the United States develops a national health insurance plan like many other nations of the world, health insurance will continue to be a booming business. People can not do without health insurance, or they will be forced to pay astronomical out-of-pocket costs. United Healthcare has shown itself to be the strongest company in the sector. The healthcare industry is set to change under President Trump. Healthcare will no longer be mandatory. Medicaid expansion, although opposed by the new leadership, will remain in place until 2020 due to laws already passed by the previous administration. People without healthcare through employment will be offered tax credits based on income and other factors in order ...